Utility of induction agents in living donor kidney transplantation

Utility of induction agents in living donor kidney transplantation

Aim: The outcome and long-term adverse events associated with induction agent use for living donor (LD) kidney transplantation (KT) in India were studied. Materials and Methods: Consecutive LD kidney transplant recipients (KTRs) from 2005 to 2013 were studied. They were divided based on induction ag...

Full description

Bibliographic Details
Main Authors:	Radhika Chemmangattu Radhakrishnan, Gopal Basu, Anjali Mohapatra, Suceena Alexander, Anna T Valson, Shibu Jacob, Vinoi George David, Santosh Varughese, Tamilarasi Veerasami
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Indian Journal of Transplantation
Subjects:	Antithymocyte globulin basiliximab induction interleukin-2 receptor blocker kidney transplantation
Online Access:	http://www.ijtonline.in/article.asp?issn=2212-0017;year=2019;volume=13;issue=3;spage=202;epage=209;aulast=Radhakrishnan

Similar Items

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
by: Isa F. Ashoor, et al.
Published: (2021-04-01)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
by: S Gundlapalli, et al.
Published: (2013-01-01)

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
by: Jiang Qiu, et al.
Published: (2019-03-01)

Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin
by: de-Medeiros C.R., et al.
Published: (2000-01-01)

Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
by: Timothy G. Norwood, et al.
Published: (2020-02-01)

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
by: Sang Jin Kim, et al.
Published: (2020-05-01)

Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression
by: Shyam Bihari Bansal, et al.
Published: (2019-01-01)

Role of antithymocyte globulin in reducing the incidence of complications after allogeneic hemopoietic cell transplantation
by: Yu R Zalyalov, et al.
Published: (2010-08-01)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
by: G. R. Pourmand, et al.
Published: (2012-04-01)

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review
by: Maarten Naesens, et al.
Published: (2016-09-01)

Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review
by: Maarten Naesens, et al.
Published: (2016-09-01)

Study of Aplastic Anaemia with Cyclosporine in Resource Poor Setting
by: Mallikarjuna Shetty, et al.
Published: (2016-06-01)

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
by: Eolia Brissot, et al.
Published: (2020-07-01)

The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia
by: A A Ganapiyev, et al.
Published: (2010-07-01)

Immunological barriers in ABO-incompatible kidney transplantation: How to overcome
by: Sonia Mehrotra, et al.
Published: (2019-01-01)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
by: Yohan Park, et al.
Published: (2020-07-01)

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
by: Mohamed Hashim, et al.
Published: (2020-09-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
by: Ren Lin, et al.
Published: (2019-08-01)

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience
by: Vipul Sheth, et al.
Published: (2019-07-01)

Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007–2016)
by: E. A. Mikhaylova, et al.
Published: (2020-09-01)

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
by: Florent Malard, et al.
Published: (2018-10-01)

The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era
by: Radhika Chemmangattu Radhakrishnan, et al.
Published: (2018-01-01)

Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
by: Taeyun Kim, et al.
Published: (2020-03-01)

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
by: Tobias Roider, et al.
Published: (2016-12-01)

Hallazgos histológicos en biopsia por protocolo asociados con reducción en función renal 12 meses postrasplante, en receptores de trasplante renal con bajo riesgo inmunológico, recibiendo inducción con basiliximab
by: Jairo Camilo Montero Cetina, et al.
Published: (2019-03-01)

Use of a “CNI holidays” strategy in acute renal dysfunction late after heart transplant. Report of two cases
by: Pau Alonso, et al.
Published: (2014-12-01)

Agentes imunossupressores, talidomida e ácido valpróico nas síndromes mielodisplásicas Immunosuppressive agents, thalidomide and valproate acid in myelodysplastic syndromes
by: Elvira R. P. Velloso
Published: (2006-09-01)

Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes
by: Yu Wang, et al.
Published: (2017-11-01)

Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application
by: A D Kulagin, et al.
Published: (2010-07-01)

Effects of individualized dialysate sodium prescription in hemodialysis – Results from a prospective interventional trial
by: Radhika C Radhakrishnan, et al.
Published: (2020-01-01)

Rituximab-induced urticarial dermatitis during the treatment of membranous nephropathy
by: Radhika Chemmangattu Radhakrishnan, et al.
Published: (2017-01-01)

INDUCTION OF IL-8 PRODUCTION BY THE METAL COMPLEXES OF γ-GLOBULIN FORMED WITH ZINC IONS
by: M. A. Apresova, et al.
Published: (2014-07-01)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
by: Mysore K. Phanish, et al.
Published: (2020-03-01)

Clinical-economic impact of the change of protocol for use of basiliximab in liver transplant
by: Enrique Tévar-Alfonso, et al.
Published: (2019-01-01)

Treating a GAD65 antibody-associated limbic encephalitis with Basiliximab, a case study
by: Guido eWidman, et al.
Published: (2015-08-01)

Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child
by: In Su Choi, et al.
Published: (2015-07-01)

Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
by: Hui-Ying Liu, et al.
Published: (2019-08-01)

Fatal anaphylactic reaction due to Basiliximab
by: Patricia Lovisolo, et al.
Published: (2017-04-01)

Cannot write session to /tmp/vufind_sessions/sess_o7jfs78fkuu5vl1rg5gielo4tr